Literature DB >> 27490097

Combinatorial Solid-Phase Synthesis and Biological Evaluation of Cyclodepsipeptide Destruxin B as a Negative Regulator for Osteoclast Morphology.

Hiroshi Sato1,2, Masahito Yoshida1, Hayato Murase3, Hiroshi Nakagawa3, Takayuki Doi1.   

Abstract

Combinatorial synthesis and biological evaluation of cyclodepsipeptide destruxin B have been achieved. The cyclization precursors were prepared by solid-phase peptide synthesis via a split and pool method utilizing SynPhase lanterns with colored tags and cogs, followed by cleavage from the polymer-support. Macrolactonization utilizing MNBA-DMAPO in solution-phase was successfully performed in parallel to afford the desired 64-member destruxin analogues in moderate to good yields. Biological evaluation of the synthesized analogues indicated that a MeAla residue for the building block A is required to induce the desired morphological changes in osteoclast-like multinuclear cells (OCLs), and introduction of the substituent at the R(4) position of a proline moiety is tolerated by the morphology and may enable the preparation of a molecular probe for the target identification in the osteoclasts.

Entities:  

Keywords:  combinatorial library; cyclic peptides; cyclodepsipeptides; osteoclasts; solid-phase synthesis

Mesh:

Substances:

Year:  2016        PMID: 27490097     DOI: 10.1021/acscombsci.6b00076

Source DB:  PubMed          Journal:  ACS Comb Sci        ISSN: 2156-8944            Impact factor:   3.784


  2 in total

1.  Anti-inflammatory effects of peptides from a marine algicolous fungus Acremonium sp. NTU492 in BV-2 microglial cells.

Authors:  George Hsiao; Shih-Wei Wang; Yin-Ru Chiang; Wei-Chiung Chi; Yueh-Hsiung Kuo; Do Anh Phong; Chia-Yu Chen; Tzong-Huei Lee
Journal:  J Food Drug Anal       Date:  2020-06-15       Impact factor: 6.157

2.  Efficient Chemoenzymatic Synthesis of (2S,3R)-3-Hydroxy-3-Methylproline, a Key Fragment in Polyoxypeptin A and FR225659.

Authors:  Xiao Zhang; Hans Renata
Journal:  Tetrahedron       Date:  2019-04-05       Impact factor: 2.457

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.